Trial Profile
Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST): a Randomized Feasibility Trial
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fibrinogen (Primary)
- Indications Wounds and injuries
- Focus Adverse reactions; Therapeutic Use
- Acronyms FiiRST
- 13 Apr 2016 Status changed from recruiting to completed according to the ClinicalTrials.gov.record
- 28 Oct 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 01 Aug 2014 New trial record